ST

Suchita Tiwari Verma

Active Director Designated Partner DIN 11032090
DIN 11032090 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Suchita Tiwari Verma

Data last updated:

Suchita Tiwari Verma is a Designated Partner at Kristeva Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11032090
Primary Designation Designated Partner
Industry Pharma
First Appointment 01 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Apr 20252025Active

Board colleagues of Suchita Tiwari Verma

NameDINCompanyDesignation
Nandini Roy Banik11032091Kristeva Pharmaceuticals LlpDesignated Partner
Sneha Dowerah11032093Kristeva Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Kristeva Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Suchita Tiwari Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suchita Tiwari Verma

Suchita Tiwari Verma currently holds 1 directorship: Kristeva Pharmaceuticals Llp (Designated Partner, since 01 Apr 2025).

Suchita Tiwari Verma was first appointed on 01 Apr 2025 as Designated Partner at Kristeva Pharmaceuticals Llp.

The current boards of Suchita Tiwari Verma's companies include Nandini Roy Banik (Kristeva Pharmaceuticals Llp), Sneha Dowerah (Kristeva Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available